Cite
HARVARD Citation
Mullol, J. et al. (2022). Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials. Allergy. 77 (4), pp. 1231-1244. [Online].